Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C11-Acetate PET in Recurrent Prostate Cancer
NCT01304485Phase 2Completed
- Sponsor
- Phoenix Molecular Imaging
- Start
- Apr 2011
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carbon-11 acetate in prostate cancer (PCa), sponsored by Phoenix Molecular Imaging. Started Apr 2011; status: completed.
02
Drugs
carbon-11 acetate
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01304485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01304485.